- Home
- SABS vs UMAC Comparison
SABS vs UMAC Comparison
Compare SABS & UMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- UMAC
- Stock Information
- Founded
- SABS 2014
- UMAC 2019
- Country
- SABS United States
- UMAC United States
- Employees
- SABS N/A
- UMAC N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- UMAC
- Sector
- SABS Health Care
- UMAC
- Exchange
- SABS Nasdaq
- UMAC Nasdaq
- Market Cap
- SABS 23.9M
- UMAC 20.4M
- IPO Year
- SABS N/A
- UMAC 2024
- Fundamental
- Price
- SABS $3.10
- UMAC $2.62
- Analyst Decision
- SABS Strong Buy
- UMAC Strong Buy
- Analyst Count
- SABS 5
- UMAC 1
- Target Price
- SABS $12.40
- UMAC $4.00
- AVG Volume (30 Days)
- SABS 78.1K
- UMAC 139.7K
- Earning Date
- SABS 11-06-2024
- UMAC 11-14-2024
- Dividend Yield
- SABS N/A
- UMAC N/A
- EPS Growth
- SABS N/A
- UMAC N/A
- EPS
- SABS N/A
- UMAC N/A
- Revenue
- SABS $1,512,723.00
- UMAC $3,561,303.00
- Revenue This Year
- SABS N/A
- UMAC N/A
- Revenue Next Year
- SABS N/A
- UMAC $66.18
- P/E Ratio
- SABS N/A
- UMAC N/A
- Revenue Growth
- SABS N/A
- UMAC N/A
- 52 Week Low
- SABS $2.16
- UMAC $0.98
- 52 Week High
- SABS $9.72
- UMAC $5.54
- Technical
- Relative Strength Index (RSI)
- SABS 48.28
- UMAC 58.78
- Support Level
- SABS $3.17
- UMAC $2.45
- Resistance Level
- SABS $3.74
- UMAC $3.53
- Average True Range (ATR)
- SABS 0.48
- UMAC 0.48
- MACD
- SABS -0.04
- UMAC 0.10
- Stochastic Oscillator
- SABS 17.53
- UMAC 56.25
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About UMAC Unusual Machines Inc. Common Stock
Unusual Machines Inc is a development stage technology company.